About the Junction TMO

In the 1990s, Pfizer Biotech (formerly Wyeth) and P&G/Gillette (formerly The Gillette Company) began working with other local businesses, property owners and public officials to reduce traffic congestion, improve air quality, advocate for local road improvements, and increase commuting alternatives for area employees. To that end, the Junction Transportation Management Organization, Inc. (JTMO) was formed as a consensus-oriented, nonprofit organization of private and public sector representatives working together to address transportation issues in the Ballardvale St./Lowell Junction area of Andover and Wilmington and nearby areas. The JTMO now has nine corporate members and five ex-officio members.

The JTMO offers a range of commuter services, including ride matching for carpools and vanpools, a popular Bike-to-Work program and a free Emergency Ride Home Program. In addition, the JTMO hosts on-site educational events and encourages commuter friendly options like preferred parking, on-site food services, showers, fitness centers, bike racks, ATMs, and pickup and delivery laundry services. Central to the JTMO's efforts are enhanced seasonal promotions that engage employees and provide incentives for commuters to switch from driving alone to ridesharing.

As a strong advocate for the I-93 Tri-Town Interchange, the Junction TMO has submitted public comments over the years during various stages of the project and is committed to developing a unified transportation demand management strategy for the project as it evolves. The JTMO supports double tracking the Haverhill commuter rail line, building a new Junction rail stop, forming a Bus-On-Shoulder route on I-93, and (in the future) instituting a local shuttle serving the I-93 Tri-Town development Area.

Finally, the JTMO provides assistance to its members in complying with the state Department of Environmental Protection's RideShare reporting requirements and in meeting the criteria for being recognized as one of the Best Workplaces for Commuters™.